RIG
ALXN

Roosevelt Investment Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Roosevelt Investment Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6,925
Closed -$964K – 207
2016
Q1 		$964K Sell
6,925
-699
-9% -$103K 0.09% 102
2015
Q4 		$1.45M Sell
7,624
-250
-3% -$43.7K 0.1% 111
2015
Q3 		$1.23M Hold
7,874
– – 0.08% 121
2015
Q2 		$1.42M Sell
7,874
-100
-1% -$17.3K 0.08% 123
2015
Q1 		$1.38M Buy
7,974
+100
+1% +$18.1K 0.08% 118
2014
Q4 		$1.46M Sell
7,874
-358
-4% -$66.3K 0.08% 121
2014
Q3 		$1.36M Sell
8,232
-51
-0.6% -$8.38K 0.07% 121
2014
Q2 		$1.29M Sell
8,283
-2,889
-26% -$456K 0.06% 122
2014
Q1 		$1.7M Sell
11,172
-391
-3% -$62.2K 0.08% 103
2013
Q4 		$1.54M Buy
11,563
+267
+2% +$32K 0.07% 120
2013
Q3 		$1.31M Sell
11,296
-2,063
-15% -$226K 0.06% 125
2013
Q2 		$1.23M Buy
+13,359
New +$1.29M 0.06% 128

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return